Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Options Medical Weight Loss vs Wellorithm

Options Medical Weight Loss
Graded #218

Higher grade

vs+17
Wellorithm
Graded #486

Lower grade

The verdict

Options Medical Weight Loss takes it — 65.5/100 to 48.5/100.

Options Medical Weight Loss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Options Medical Weight Loss offers telehealth medical weight-loss programs built around compounded GLP-1 — semaglutide starting around $239/month and tirzepatide from $299/month, plus NAD+ injections at…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOptions Medical Weight Loss +24
54
30
Dose & formulationWellorithm +15
77
92
Clinical oversightOptions Medical Weight Loss +53
81
28
Labs & monitoringOptions Medical Weight Loss +13
53
40
FulfillmentOptions Medical Weight Loss +5
67
62
Contract termsOptions Medical Weight Loss +10
55
45
Options Medical Weight Loss · left barWellorithm · right bar

The numbers

MetricOptions Medical Weight LossWellorithm
WeighScore65.5/10048.5/100
GradeCC
Scorecard rank#218#486
Semaglutide$199/mo (compounded)Pricing not published
Tirzepatide$399/mo (compounded)Pricing not published
CoverageCoverage not published49 states (not Louisiana)
Brand-name accessYesYes
Oral / sublingualInjection onlyYes

Strengths

  • LegitScript certified with clear, upfront program pricing
  • Compounded semaglutide (~$239) and tirzepatide (from $299), plus NAD+
  • Structured metabolic-health program with provider support and accountability
  • HSA/FSA eligible with flexible payment options

Where it loses points

  • Doesn't clearly publish which states its telehealth covers
  • Tirzepatide tiers climb to $339-$399/month
  • More program structure (and cost) than medication-only sellers
  • Compounded GLP-1 only online — no brand-name options noted
Wellorithm

Graded #486 · C

Strengths

  • Both molecules in BOTH routes — compounded semaglutide and tirzepatide as injections and as oral dissolving tablets
  • Four branded pens on the same account: Mounjaro, Ozempic, Wegovy and Zepbound
  • Sermorelin offered alongside the GLP-1 line
  • 24/7 phone support on a published number

Where it loses points

  • No price appears anywhere on the public site — /pricing 404s and every product CTA leads to a 2-minute intake quiz, so no cost can be compared before signing up
  • The site contradicts itself on coverage: the homepage says "Serving All 50 States" while its own FAQ says 49 states and excludes Louisiana
  • The four clinicians presented as "board-certified obesity specialists" are listed as Cardiac Surgery, Pediatric Clinic, Gynecology and Cardiac Surgery — none in obesity medicine
  • "100% Customer Satisfaction" is stated as a headline fact and is not a substantiable claim

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard